CD8A and COVID-19: A hallmark of patients with severe COVID-19 is lymphopenia [8], characterized by a dramatic decrease in CD4+ and CD8+ T cells [8], CD8+ mucosal-associated invariant T (MAIT), and γδ T cells [9].